Piper Sandler Just Hiked Humana Target to $254
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Consider year long money challenges to maintain consistent savings throughout the year. Commit to your financial goals today!
27,226 articlesPiper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...
Investors face a pivotal choice in 2026: a dependable defense powerhouse or a cyclical recovery in commercial aviatio...
When SpaceX delays its Starship launch, traders take note. But the real question for investors isn’t the setback itse...
A 59-year-old faces a six-figure tax bill after an indirect IRA rollover violated the once-per-year rollover rule 59-...
Rivian stock fell first half 2026 as a mix of delivery updates, new model momentum, and macro headwinds shaped invest...
A public feud over college’s worth heats up in 2026 as Peter Thiel backs alternatives with large grants. The former g...
A major fund exit and shifting industry dynamics pushed acadia healthcare stock tanked into focus. This guide breaks ...
A look back at how a $1,000 investment split between Visa and AMEX in 2016 would fare today, highlighting the differe...
A major fund sold a sizable stake in Darling Ingredients, but the stock defied expectations and surged. This article ...
Investing in semiconductors means weighing two heavyweight names: Intel and TSMC. This guide breaks down the landscap...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...